ArticleFrontiers in pharmacology2021

Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma.

Ye Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.